Actinium Pharmaceuticals reported $-15.94M in Pre-Tax Profit for its fiscal quarter ending in March of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Actinium Pharmaceuticals USD -15.94M 9.29M Mar/2025
Amgen USD 3.92B 2.35B Sep/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Pfizer USD 3.33B 290M Sep/2025